![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SANOFI DENIES FDA ASKING FOR ACOMPLIA SAFETY DATA FROM DIET DRUG SALES IN EUROPE
SANOFI DENIES FDA ASKING FOR ACOMPLIA SAFETY DATA FROM DIET DRUG SALES IN EUROPE
While Sanofi-Aventis is busily gathering data on patient use of diet drug Acomplia in Europe to track side effects that may emerge during its initial months of sale, the company denied Oct. 6 that FDA has asked for more safety data as it weighs approving the diet pill for sale in the United States. Acomplia Report (http://www.acompliareport.com/News/news-100806.htm)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct